Written Question·Department of Health and Social Care·UIN 110593

Idiopathic Pulmonary Fibrosis: Drugs

Tabled: 3 February 2026
Answered: 12 February 2026
Named Day

Question

Michael Wheeler

LabourWorsley and Eccles

To ask the Secretary of State for Health and Social Care, whether his Department has considered the implications of the UK-US Economic Prosperity Deal for the potential approval of Jascayd (nerandomilast).

Answer

Dr Zubir Ahmed
No specific consideration of the implications of the United Kingdom and United States’ Economic Prosperity Deal for the approval of Jascayd (nernadomilast) has been made. The changes that we are making to the way in which the National Institute for Health...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 110593) →